M.E

Professionals having proven competency and success in their area of specialization, with at least 10 years of post- qualification experience and should possess minimum M.Sc, B.Tech, BE, MCA, MPH, B.Pharma, BAMS, BSMS, MD in AYUSH Or equivalent qualifications in relevant subject. 

Characterization of Novel Anti-BCMA Antibody Drug Conjugate as an Immunotherapeutic Agent for Multiple Myeloma. M.Pharm, ME, M.Tech degree holders with relevant experience in the cancer research. First Class Post Graduate degree MSc in life sciences, Biochemistry, Biotechnology, Microbiology, Molecular Oncology, including the integrated PG degree with three years of experience

Entrepreneurship experience gained through/having been part of the founding team of a startup shall be given added advantage. Prior experience in the incubation or Entrepreneurship development sector shall be an added advantage. Strong track record of having built and managed multi-disciplinary teams, with proven leadership, execution, and networking skills.

Develop study protocols, standard operating procedures, and other essential documents in line with regulatory guidelines. Oversee the implementation of study activities, ensuring adherence to timelines, quality standards, and Good Clinical Practice guidelines. 

Epidemic preparedness through rapid vaccine development: support of Indian vaccine development aligned with the global initiative of the Coalition for Epidemic Preparedness Innovations. M.Sc. in Life Sciences, Bioinformatics with two years of post-qualification experience in the relevant field. OR M.E, M.Tech. in Life Sciences, Computer Science, Bioinformatics. Epidemic preparedness through rapid vaccine development, support of Indian vaccine development aligned with the global initiative of the Coalition for Epidemic Preparedness Innovations

PhD or MBA, PGDM or PMP certification with any science, engineering, management bachelor degree with 3 years of experience in startup incubators or MSc, MTech, MS, M.Pharm, ME with at least 5 years of experience in startup incubators. 

Comprehensive sero-profiling post Ivermectin, Diethylcarbamazine and Albendazole administration: Designing endpoints for Lymphatic Filariasis elimination. M.Pharm., M.V.Sc., or equivalent degree with high academic attainment and at least two years research experience after M. Sc. etc.

Biocon Biologics is driven by a strong sense of purpose and the unwavering commitment to serve patients and healthcare systems across the globe by unlocking equitable access to high quality biosimilars.

M.Pharm with minimum four years experience in medicinal & aromatic plants OR PhD in Botany, Life science, Pharmacy. 1st class M.E, M.Tech, M.Sc. in relevant branch of Engineering and Technology, Materials Science, Chemistry and Polymer Science